Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT02510859
Eligibility Criteria:
Inclusion Criteria:
* patients over 18 years
* having Given written consent
* Life span \> 3 months
* Score WHO \<3
* Patient With cancer of Aero-Digestive tract Superior histologically proven (including salivary glands)
* Stable , presenting no other progressive neoplasia except VADS
* Patient to be treated with radiotherapy alone or concomitant chemoradiotherapy or radiotherapy with cetuximab or postoperative radiotherapy roughly sensitized.
* Patient Fluent French.
Exclusion Criteria:
* Patient with history of malignancy, except basal cell cancer or neck cancer treated and cured
* Patient who underwent salvage surgery other than a course node,
* Patient with other evolutionary neoplasia at the time of examination
* Patient having previously had a mutilating surgery (causing effects on swallowing and feeding)
* Uncontrolled infectious disease
* Lactating or pregnant women or lack of contraception in reproductive years
* Intercurrent pathology involving life-threatening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02510859
Study Brief:
Protocol Section:
NCT02510859